Effects of Ido1 on mouse decidualization

被引:0
|
作者
D.-D. Li
Y.-H. Yin
J.-Y. Wu
Z.-Q. Yang
H. Cao
Q.-L. Zhang
B. Guo
Z.-P. Yue
机构
[1] Jilin University,College of Veterinary Medicine
[2] Guizhou Minzu University,Department of Laboratory Medicine
[3] General Hospital of Jinan Military Region of PLA,undefined
来源
Molecular Biology | 2015年 / 49卷
关键词
Ido1; decidualization; uterus; mouse;
D O I
暂无
中图分类号
学科分类号
摘要
Indoleamine 2,3-dioxygenase 1 (Ido1) is a rate-limiting enzyme which converts the essential amino acid tryptophan to kynurenine. The aim of this study was to investigate the expression and regulation of Ido1 in mouse uterus during decidualization. The results showed that Ido1 mRNA expression gradually increased from day 1 to 4 of pregnancy and reached the peak level on day 4. On days 5–8 of pregnancy, a low level of Ido1 expression was observed in the uteri. Simultaneously, Ido1 mRNA was also lowly expressed in the decidualized uterus and the stromal cells treated with 8-Br-cAMP. Under in vitro decidualization, the expression of Ido1 mRNA gradually declined. Further studies found that overexpression of Ido1 can inhibit the expression of decidualization marker genes PRL, IGFBP1 and Dtprp under in vitro decidualization while inhibition of Ido1 with L-1-MT can induce the expression of these marker genes. Ido1 can prevent uterine stromal cells proliferation and enhance the expression of the Bax gene and increase the Bax/Bcl2 ratio under in vitro decidualization. Additionally, Ido1 can also modulate the expression of the MMP2 gene. In the uterine stromal cells, estrogen and progesterone can stimulate the expression of Ido1. These data indicate that Ido1 may play an important role during mouse decidualization and may be regulated by estrogen and progesterone in the uterine stromal cells.
引用
收藏
页码:581 / 588
页数:7
相关论文
共 50 条
  • [31] Issues with the Specificity of Immunological Reagents for Murine IDO1
    Van de Velde, Lee-Ann
    Gingras, Sebastien
    Pelletier, Stephane
    Murray, Peter J.
    CELL METABOLISM, 2016, 23 (03) : 389 - 390
  • [32] TARGETING IDO1 IN HUMAN PEDIATRIC BRAIN CANCER
    Lauing, Kristen
    Lulla, Rishi
    Lenzen, Alicia
    Zhai, Lijie
    Hashizume, Rintaro
    Fangusaro, Jason R.
    Wainwright, Derek
    NEURO-ONCOLOGY, 2017, 19 : 120 - 120
  • [33] Innovative drugs targeting IDO1 functions in neoplasia
    Grohmann, U.
    Macchiarulo, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 1 - 1
  • [34] IDO1 Is Strongly Expressed in Placental Chronic Villitis
    Bale, T. A.
    Yang, E. J.
    Jimenez, C.
    Yuan, L.
    Quade, B. J.
    MODERN PATHOLOGY, 2014, 27 : 275A - 275A
  • [35] IDO1 regulates the NLRP3 Inflammasome
    Ganoza, C.
    Dorhoi, A.
    Fae, K. C.
    Alves, P.
    Houthuys, E.
    Guhlich-Bornhof, U.
    Hurwitz, R.
    Kaufmann, S. H. E.
    IMMUNOLOGY, 2012, 137 : 6 - 6
  • [36] The ups, downs and new trends of IDO1 inhibitors
    Chen, Shulun
    Tan, Jing
    Zhang, Ao
    BIOORGANIC CHEMISTRY, 2021, 110
  • [37] IDO1 Is Strongly Expressed in Placental Chronic Villitis
    Bale, T. A.
    Yang, E. J.
    Jimenez, C.
    Yuan, L.
    Quade, B. J.
    LABORATORY INVESTIGATION, 2014, 94 : 275A - 275A
  • [38] Discovery of IDO1 Inhibitors: From Bench to Bedside
    Prendergast, George C.
    Malachowski, William P.
    DuHadaway, James B.
    Muller, Alexander J.
    CANCER RESEARCH, 2017, 77 (24) : 6795 - 6811
  • [39] N-acetylserotonin exerts neuroprotective effects enhancing IDO1 catalytic activity
    Panfili, E.
    Volpi, C.
    Mondanelli, G.
    Santambrogio, L.
    Grohmann, U.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 192 - 192
  • [40] A novel IDO1 inhibitor combined with targeted immunotherapy durably increases survival in a mouse model of glioblastoma
    Ladomersky, Erik
    Zhai, Lijie
    Gritsina, Galina
    Lauing, Kristen L.
    Genet, Matthew
    James, C. David
    Wainwright, Derek A.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)